Enlivex Therapeutics Ltd. (ENLV)
1.01
-0.04
(-3.81%)
USD |
NASDAQ |
Feb 20, 16:00
1.01
0.00 (0.00%)
After-Hours: 20:00
Enlivex Therapeutics EPS Diluted (Quarterly) : -0.0917 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Compugen Ltd. | -0.0746 |
| Pluri, Inc. | -0.7066 |
| BioLineRx Ltd. | -0.223 |
| XTL Biopharmaceuticals Ltd. | -0.0292 |
| Can-Fite BioPharma Ltd. | -- |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.205M |
| Total Expenses (Quarterly) | 2.205M |
| Enterprise Value | 222.14M |
| Earnings Yield | -52.89% |
| Normalized Earnings Yield | -52.88 |